切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - GLI - Protein polybromo-1 - Androgen Receptors

14件产品中的 1-10

页面
每页
清除全部
  1. ODM-201
    A8452 ODM-201
    中文名: 达洛鲁胺
    Target: Androgen Receptors
    Summary: 新一代雄激素受体抑制剂
      ≥19.95 mg/mL
      insoluble in H2O
  2. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: Polybromo 1和SMARCA4抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  3. DL-Adrenaline
    B1326 DL-Adrenaline
    中文名: DL-肾上腺素
    Target: Androgen Receptors
    Summary: 肾上腺素能受体激动剂
      ≥18.3 mg/mL
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. TOK-001
    A8623 TOK-001
    中文名: 加来特龙,伽来特隆
    Target: Androgen Receptors|Cytochrome P450 (CYP450)
    Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
      ≥12.4 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. GANT61
    A1615 GANT61
     1 Citation
    Target: GLI
    Summary: GLI拮抗剂
      insoluble in DMSO
      insoluble in H2O

14件产品中的 1-10

页面
每页